The approach to the patient who refuses blood transfusion

Transfusion

Volumn 46, Issue 9, 2006, Pages 1471-1477

  Rogers, David M ^a   Crookston, Kendall P ^a,b  

^a TRICORE REFERENCE LABORATORIES   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD COMPONENT THERAPY; BLOOD TRANSFUSION; CONFIDENTIALITY; DOCTOR PATIENT RELATION; HEALTH CARE ACCESS; HEALTH CARE PERSONNEL; HUMAN; MEDICAL DECISION MAKING; PATIENT CARE; PATIENT DECISION MAKING; PHYSICIAN; REVIEW; RISK ASSESSMENT; TREATMENT REFUSAL;

BENEFICENCE; BLOOD SUBSTITUTES; BLOOD TRANSFUSION; CONFIDENTIALITY; HUMANS; INFORMED CONSENT; JEHOVAH'S WITNESSES; RISK ASSESSMENT; TREATMENT REFUSAL;

EID: 33748296087     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2006.00947.x     Document Type: Review

References (37)

1. Henderson R, Jabbour N, Zeger G. Legal and administrative issues relate to transfusion-free medicine and surgery. In: Jabbor N, editor. Transfusion-free medicine and surgery. Malden (MA): Blackwell Publishing; 2005. p. 1-23.
2. Nash MJ, Cohen H. Management of Jehovah's Witness patients with haematological problems. Blood Rev 2004;18:211-7.
3. Gyamfi C, Gyamfi MM, Berkowitz RL. Ethical and medicolegal considerations in the obstetric care of a Jehovah's Witness. Obstet Gynecol 2003;102:173-80.
4. Consensus conference: perioperative red blood cell transfusion. JAMA 1988;260:2700-3.
5. Practice strategies for elective red blood cell transfusion. Am College Phys Ann Intern Med 1992;116:403-6.
6. Viele MK, Weiskopf RB. What can we learn about the need for transfusion from patients who refuse blood? The experience with Jehovah's Witnesses. Transfusion 1994;34:396-401.
7. Goodnough LT. Risks of blood transfusion. Anesthesiol Clin North Am 2005;23:241-52.
8. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999;340:409-17.
9. Corwin HL, Gettinger A, Pearl RG, et al. The CRIT Study: Anemia and blood transfusion in the critically ill - current clinical practice in the United States. Crit Care Med 2004;32:39-52.
10. Bodnaruk ZM, Wong CJ, Thomas MJ. Meeting the clinical challenge of care for Jehovah's Witnesses. Transfus Med Rev 2004;18:105-16.
11. Watchtower Bible and Tract Society. Rightly value your gift of life. Watchtower 2004 Jun 15; 14-6.
12. Bennett DR, Shulman IA. Practical issues when confronting the patient who refuses blood transfusion therapy. Am J Clin Pathol 1997;107(4 Suppl 1):S23-7.
13. Finucane ML, Slovic P, Mertz CK. Public perception of the risk of blood transfusion. Transfusion 2000;40:1017-22.
14. Muramoto O. Bioethical aspects of the recent changes in the policy of refusal of blood by Jehovah's Witnesses. Br Med J 2001;322:37-9.
15. Malyon D. Transfusion-free treatment of Jehovah's Witnesses: respecting the autonomous patient's rights. J Med Ethics 1998;24:302-7.
16. Marsh JC, Bevan DH. Haematological care of the Jehovah's Witness patient. Br J Haematol 2002;119:25-37.
17. Doyle DJ. Blood transfusions and the Jehovah's Witness patient. Am J Ther 2002;9:417-24.
18. Ballen KK, Becker PS, Yeap BY, et al. Autologous stem-cell transplantation can be performed safely without the use of blood-product support. J Clin Oncol 2004;22:4087-94.
19. Laszlo D, Agazzi A, Goldhirsch A, et al. Tailored therapy of adult acute leukaemia in Jehovah's Witnesses: unjustified reluctance to treat. Eur J Haematol 2004;72:264-7.
20. Goodnough LT, Shander A, Spence R. Bloodless medicine: clinical care without allogeneic blood transfusion. Transfusion 2003;43:668-76.
21. Martyn V, Farmer SL, Wren MN, et al. The theory and practice of bloodless surgery. Transfus Apher Sci 2002;27:29-43.
22. Spiess BD, Spence RK, Shander A, editors. Perioperative transfusion medicine. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2005.
23. Fowler RA, Rizoli SB, Levin PD, Smith T. Blood conservation for critically ill patients. Crit Care Clin 2004;20:313-24, x.
24. Shander A, Goodnough LT, Ratko T, et al. Consensus recommendations of the off-label use of recombinant human factor VIIa (NovoSeven) therapy. P&T 2005;30:644-58.
25. Brecher ME, Goodnough LT. The rise and fall of preoperative autologous blood donation. Transfusion 2001;41:1459-62.
26. Shander A, Rijhwani TS. Acute normovolemic hemodilution. Transfusion 2004;44(12 Suppl):26S-34S.
27. Crosby E. Perioperative use of erythropoietin. Am J Ther 2002;9:371-6.
28. Goodnough LT. Autologous blood donation. Anesthesiol Clin North Am 2005;23:263-70.
29. Thyes C, Spahn DR. Current status of artificial O2 carriers. Anesthesiol Clin North Am 2005;23:373-89.
30. Inayat MS, Bernard AC, Gallicchio VS, et al. Oxygen carriers: a selected review. Transfus Apher Sci 2006;34:25-32.
31. Bartlett R. Oxygen therapeutics - the quest for artificial blood. In: Jabbor N, editor. Transfusion-free medicinne and surgery. Boston: Blackwell Publishing; 2005. p. 254-82.
32. Watchtower Bible and Tract Society. Questions from readers: do Jehovah's Witnesses accept any medical products derived from blood? Watchtower 2000 Jun 15; 29-31.
33. Gyamfi C, Berkowitz RL. Responses by pregnant Jehovah's Witnesses on health care proxies. Obstet Gynecol 2004;104:541-4.
34. Meier DE, Back AL, Morrison RS. The inner life of physicians and care of the seriously ill. JAMA 2001;286:3007-14.
35. Informed consent, parental permission, and assent in pediatric practice. Committee on Bioethics, American Academy of Pediatrics. Pediatrics 1995;95:314-7.
36. Greensmith JE. Hyperbaric oxygen reverses organ dysfunction in severe anemia. Anesthesiology 2000;93:1149-52.
37. Van Meter KW. A systematic review of the application of hyperbaric oxygen in the treatment of severe anemia: an evidence-based approach. Undersea Hyperb Med 2005;32:61-83.